These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 2943036)
1. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion. Sigurdson ER; Ridge JA; Daly JM Surgery; 1986 Aug; 100(2):285-91. PubMed ID: 2943036 [TBL] [Abstract][Full Text] [Related]
2. Tumor and liver drug uptake following hepatic artery and portal vein infusion. Sigurdson ER; Ridge JA; Kemeny N; Daly JM J Clin Oncol; 1987 Nov; 5(11):1836-40. PubMed ID: 3681370 [TBL] [Abstract][Full Text] [Related]
3. Distribution of fluorodeoxyuridine uptake in the liver and colorectal hepatic metastases of human beings after arterial infusion. Ridge JA; Sigurdson ER; Daly JM Surg Gynecol Obstet; 1987 Apr; 164(4):319-23. PubMed ID: 2951882 [TBL] [Abstract][Full Text] [Related]
6. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. Lorenz M; Müller HH J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236 [TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279 [TBL] [Abstract][Full Text] [Related]
8. Hepatic artery versus portal vein and systemic infusion of fluorodeoxyuridine of rabbit VX-2 hepatic implants. Butler JA; Trezona TP; Nordestgaard A; State D Am J Surg; 1989 Jan; 157(1):126-9. PubMed ID: 2521278 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver. Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376 [TBL] [Abstract][Full Text] [Related]
10. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951 [TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer. Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Kemeny N; Seiter K; Niedzwiecki D; Chapman D; Sigurdson E; Cohen A; Botet J; Oderman P; Murray P Cancer; 1992 Jan; 69(2):327-34. PubMed ID: 1303612 [TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315 [TBL] [Abstract][Full Text] [Related]
15. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Ridge JA; Bading JR; Gelbard AS; Benua RS; Daly JM Cancer; 1987 May; 59(9):1547-53. PubMed ID: 3828954 [TBL] [Abstract][Full Text] [Related]
16. Regional chemotherapy of colorectal cancer metastatic to the liver. Niederhuber JE; Ensminger W; Gyves J; Thrall J; Walker S; Cozzi E Cancer; 1984 Mar; 53(6):1336-43. PubMed ID: 6229326 [TBL] [Abstract][Full Text] [Related]
17. [Locoregional chemotherapy of hepatic metastases of colorectal cancer]. Rougier P; Lasser P; Droz JP; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):315-9. PubMed ID: 2962534 [TBL] [Abstract][Full Text] [Related]
18. On the differential affinities of two anticancer analogues to their target. Holl E; Zänker KS; Lange J; Siewert JR Drugs Exp Clin Res; 1985; 11(2):133-9. PubMed ID: 2941256 [TBL] [Abstract][Full Text] [Related]
19. The effects on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR. Kemeny MM; Alava G; Oliver JM HPB Surg; 1994; 7(3):219-24. PubMed ID: 8155588 [TBL] [Abstract][Full Text] [Related]
20. Technetium-99m labelled macroaggregated albumin arterial catheter perfusion scintigraphy: prediction of gastrointestinal toxicity in hepatic arterial chemotherapy. Pelosi E; Masaneo I; Clara R; Valetto MR; Bellò M; Zanon C; Chiappino I; Grosso M; Mussa A; Bisi G Eur J Nucl Med; 2000 Jun; 27(6):668-75. PubMed ID: 10901453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]